시장보고서
상품코드
1866712

제대혈 보존 : 세계 시장 점유율과 순위, 총판매량 및 수요 예측(2025-2031년)

Cord Blood Storage - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

발행일: | 리서치사: QYResearch | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

세계의 제대혈 보존 시장 규모는 2024년에 16억 9,800만 달러로 추정되며, 2025-2031년의 예측 기간 중 CAGR 6.8%로 성장하며, 2031년까지 26억 7,400만 달러로 확대할 것으로 예측됩니다.

제대혈 보존이란 조혈모세포가 풍부한 제대혈을 채취, 처리 및 장기 동결보존하는 것을 말합니다. 이러한 줄기세포는 혈액과 면역체계를 재생하는 능력을 가지고 있으며, 백혈병, 림프종, 지중해빈혈 등 다양한 혈액질환과 유전성 질환의 치료에 활용되고 있습니다. 제대혈은 향후 개인이나 가족이 사용할 목적으로 사적으로 보관하거나, 관련 없는 환자가 이용할 수 있도록 공공은행에 기증할 수 있습니다. 재생의료와 세포치료의 발전에 따라 제대혈 보존은 미래의 치료 응용을 위한 귀중한 의료 자원으로 점점 더 주목받고 있습니다.

줄기세포 보존 서비스 시장은 주로 줄기세포의 치료적 잠재력에 대한 인식이 높아지고 맞춤형 의료 및 재생의료에 대한 수요가 증가함에 따라 성장하고 있습니다. 줄기세포 보존 서비스는 제대혈, 지방조직, 치수 등 다양한 원천에서 줄기세포를 채취 및 보존하여 미래의 의료적 활용을 대비할 수 있는 옵션을 제공합니다. 만성질환 증가와 새로운 치료법의 필요성이 높아지면서 손상된 조직과 장기의 재생을 기대할 수 있는 줄기세포의 보존이 추진되고 있습니다. 그러나 줄기세포의 상업화에 대한 윤리적 고려, 줄기세포 은행 및 보존에 대한 표준화된 가이드라인의 부재 등의 과제도 존재합니다. 보관 기간 중 줄기세포의 품질과 생존율을 보장하는 것은 매우 중요하며, 안전성 문제를 해결하고 줄기세포 보존 서비스에 대한 대중의 신뢰를 유지하기 위해서는 엄격한 규제 감독이 필요합니다.

이 보고서는 제대혈 보존 세계 시장에 대한 종합적인 분석을 제공하는 것을 목표로 합니다. 총매출액, 주요 기업의 시장 점유율과 순위에 초점을 맞추고, 지역별, 국가별, 유형별, 용도별 제대혈 보존 시장을 분석합니다.

제대혈 보존 시장 규모, 추정 및 예측은 2024년을 기준 연도로 하여 2020-2031년의 과거 데이터와 예측 데이터를 포함하는 판매 매출로 제공되었습니다. 양적 분석과 질적 분석을 통해 독자들이 비즈니스/성장 전략을 수립하고, 시장 경쟁 구도를 평가하고, 현재 시장에서의 위치를 분석하고, 제대혈 보존과 관련된 정보에 입각한 비즈니스 의사결정을 내리는 데 도움을 드리고자 합니다.

시장 세분화

기업별

  • CCBC
  • CBR
  • ViaCord
  • Esperite
  • Vcanbio
  • Boyalife
  • LifeCell
  • Crioestaminal
  • Cryocord
  • Cryo-cell
  • Cordlife Group
  • PBKM FamiCord
  • cells4life
  • Beikebiotech
  • StemCyte
  • Cellsafe Biotech Group
  • PacifiCord
  • Americord
  • Krio
  • Familycord
  • Cryo Stemcell
  • Vinmec Tissue Bank
  • StemCord
  • IPSC Depository
  • Thai StemLife
  • Cryoviva

유형별 부문

  • 장기 보존
  • 단기 보존

용도별 부문

  • 질환 치료
  • 헬스케어

지역별

  • 북미
    • 미국
    • 캐나다
  • 아시아태평양
    • 중국
    • 일본
    • 한국
    • 동남아시아
    • 인도
    • 호주
    • 기타 아시아태평양
  • 유럽
    • 독일
    • 프랑스
    • 영국
    • 이탈리아
    • 네덜란드
    • 북유럽 국가
    • 기타 유럽
  • 라틴아메리카
    • 멕시코
    • 브라질
    • 기타 라틴아메리카
  • 중동 및 아프리카
    • 튀르키예
    • 사우디아라비아
    • 아랍에미리트
    • 기타 중동 및 아프리카
KSA 25.12.22

자주 묻는 질문

  • 제대혈 보존 시장 규모는 어떻게 예측되나요?
  • 제대혈 보존의 정의는 무엇인가요?
  • 줄기세포 보존 서비스 시장의 성장 요인은 무엇인가요?
  • 제대혈 보존 시장의 주요 기업은 어디인가요?
  • 제대혈 보존의 용도는 무엇인가요?
  • 제대혈 보존 시장의 지역별 분포는 어떻게 되나요?

The global market for Cord Blood Storage was estimated to be worth US$ 1698 million in 2024 and is forecast to a readjusted size of US$ 2674 million by 2031 with a CAGR of 6.8% during the forecast period 2025-2031.

Cord Blood Storage refers to the collection, processing, and long-term cryopreservation of umbilical cord blood, which is rich in hematopoietic stem cells. These stem cells have the ability to regenerate blood and immune systems and are used in the treatment of various hematologic and genetic disorders such as leukemia, lymphoma, and thalassemia. Cord blood can be stored privately for potential personal or family use, or donated to public banks for use by unrelated patients. With the advancement of regenerative medicine and cellular therapy, cord blood storage is increasingly seen as a valuable medical resource for future therapeutic applications.

The stem cell storage service market is primarily driven by the increasing recognition of stem cells' therapeutic potential and the growing demand for personalized and regenerative medicine. Stem cell storage services offer the option to collect and preserve stem cells from various sources, such as umbilical cord blood, adipose tissue, and dental pulp, for future medical use. The rising prevalence of chronic diseases and the need for novel treatments propel the adoption of stem cell storage, as these cells hold promise for regenerating damaged tissues and organs. However, the market also faces challenges, including ethical considerations related to the commercialization of stem cells and the lack of standardized guidelines for stem cell banking and storage. Ensuring the quality and viability of stored stem cells throughout the storage period is critical, and stringent regulatory oversight is required to address safety concerns and maintain public trust in stem cell storage services.

This report aims to provide a comprehensive presentation of the global market for Cord Blood Storage, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Cord Blood Storage by region & country, by Type, and by Application.

The Cord Blood Storage market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cord Blood Storage.

Market Segmentation

By Company

  • CCBC
  • CBR
  • ViaCord
  • Esperite
  • Vcanbio
  • Boyalife
  • LifeCell
  • Crioestaminal
  • Cryocord
  • Cryo-cell
  • Cordlife Group
  • PBKM FamiCord
  • cells4life
  • Beikebiotech
  • StemCyte
  • Cellsafe Biotech Group
  • PacifiCord
  • Americord
  • Krio
  • Familycord
  • Cryo Stemcell
  • Vinmec Tissue Bank
  • StemCord
  • IPSC Depository
  • Thai StemLife
  • Cryoviva

Segment by Type

  • Long Term Storage
  • Short Term Storage

Segment by Application

  • Diseases Therapy
  • Healthcare

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Cord Blood Storage company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Cord Blood Storage in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Cord Blood Storage in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Cord Blood Storage Product Introduction
  • 1.2 Global Cord Blood Storage Market Size Forecast (2020-2031)
  • 1.3 Cord Blood Storage Market Trends & Drivers
    • 1.3.1 Cord Blood Storage Industry Trends
    • 1.3.2 Cord Blood Storage Market Drivers & Opportunity
    • 1.3.3 Cord Blood Storage Market Challenges
    • 1.3.4 Cord Blood Storage Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Cord Blood Storage Players Revenue Ranking (2024)
  • 2.2 Global Cord Blood Storage Revenue by Company (2020-2025)
  • 2.3 Key Companies Cord Blood Storage Manufacturing Base Distribution and Headquarters
  • 2.4 Key Companies Cord Blood Storage Product Offered
  • 2.5 Key Companies Time to Begin Mass Production of Cord Blood Storage
  • 2.6 Cord Blood Storage Market Competitive Analysis
    • 2.6.1 Cord Blood Storage Market Concentration Rate (2020-2025)
    • 2.6.2 Global 5 and 10 Largest Companies by Cord Blood Storage Revenue in 2024
    • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cord Blood Storage as of 2024)
  • 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Long Term Storage
    • 3.1.2 Short Term Storage
  • 3.2 Global Cord Blood Storage Sales Value by Type
    • 3.2.1 Global Cord Blood Storage Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Cord Blood Storage Sales Value, by Type (2020-2031)
    • 3.2.3 Global Cord Blood Storage Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Diseases Therapy
    • 4.1.2 Healthcare
  • 4.2 Global Cord Blood Storage Sales Value by Application
    • 4.2.1 Global Cord Blood Storage Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Cord Blood Storage Sales Value, by Application (2020-2031)
    • 4.2.3 Global Cord Blood Storage Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

  • 5.1 Global Cord Blood Storage Sales Value by Region
    • 5.1.1 Global Cord Blood Storage Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Cord Blood Storage Sales Value by Region (2020-2025)
    • 5.1.3 Global Cord Blood Storage Sales Value by Region (2026-2031)
    • 5.1.4 Global Cord Blood Storage Sales Value by Region (%), (2020-2031)
  • 5.2 North America
    • 5.2.1 North America Cord Blood Storage Sales Value, 2020-2031
    • 5.2.2 North America Cord Blood Storage Sales Value by Country (%), 2024 VS 2031
  • 5.3 Europe
    • 5.3.1 Europe Cord Blood Storage Sales Value, 2020-2031
    • 5.3.2 Europe Cord Blood Storage Sales Value by Country (%), 2024 VS 2031
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Cord Blood Storage Sales Value, 2020-2031
    • 5.4.2 Asia Pacific Cord Blood Storage Sales Value by Region (%), 2024 VS 2031
  • 5.5 South America
    • 5.5.1 South America Cord Blood Storage Sales Value, 2020-2031
    • 5.5.2 South America Cord Blood Storage Sales Value by Country (%), 2024 VS 2031
  • 5.6 Middle East & Africa
    • 5.6.1 Middle East & Africa Cord Blood Storage Sales Value, 2020-2031
    • 5.6.2 Middle East & Africa Cord Blood Storage Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Cord Blood Storage Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Cord Blood Storage Sales Value, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Cord Blood Storage Sales Value, 2020-2031
    • 6.3.2 United States Cord Blood Storage Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Cord Blood Storage Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Cord Blood Storage Sales Value, 2020-2031
    • 6.4.2 Europe Cord Blood Storage Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Cord Blood Storage Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Cord Blood Storage Sales Value, 2020-2031
    • 6.5.2 China Cord Blood Storage Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Cord Blood Storage Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Cord Blood Storage Sales Value, 2020-2031
    • 6.6.2 Japan Cord Blood Storage Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Cord Blood Storage Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Cord Blood Storage Sales Value, 2020-2031
    • 6.7.2 South Korea Cord Blood Storage Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Cord Blood Storage Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Cord Blood Storage Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Cord Blood Storage Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Cord Blood Storage Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Cord Blood Storage Sales Value, 2020-2031
    • 6.9.2 India Cord Blood Storage Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Cord Blood Storage Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 CCBC
    • 7.1.1 CCBC Profile
    • 7.1.2 CCBC Main Business
    • 7.1.3 CCBC Cord Blood Storage Products, Services and Solutions
    • 7.1.4 CCBC Cord Blood Storage Revenue (US$ Million) & (2020-2025)
    • 7.1.5 CCBC Recent Developments
  • 7.2 CBR
    • 7.2.1 CBR Profile
    • 7.2.2 CBR Main Business
    • 7.2.3 CBR Cord Blood Storage Products, Services and Solutions
    • 7.2.4 CBR Cord Blood Storage Revenue (US$ Million) & (2020-2025)
    • 7.2.5 CBR Recent Developments
  • 7.3 ViaCord
    • 7.3.1 ViaCord Profile
    • 7.3.2 ViaCord Main Business
    • 7.3.3 ViaCord Cord Blood Storage Products, Services and Solutions
    • 7.3.4 ViaCord Cord Blood Storage Revenue (US$ Million) & (2020-2025)
    • 7.3.5 ViaCord Recent Developments
  • 7.4 Esperite
    • 7.4.1 Esperite Profile
    • 7.4.2 Esperite Main Business
    • 7.4.3 Esperite Cord Blood Storage Products, Services and Solutions
    • 7.4.4 Esperite Cord Blood Storage Revenue (US$ Million) & (2020-2025)
    • 7.4.5 Esperite Recent Developments
  • 7.5 Vcanbio
    • 7.5.1 Vcanbio Profile
    • 7.5.2 Vcanbio Main Business
    • 7.5.3 Vcanbio Cord Blood Storage Products, Services and Solutions
    • 7.5.4 Vcanbio Cord Blood Storage Revenue (US$ Million) & (2020-2025)
    • 7.5.5 Vcanbio Recent Developments
  • 7.6 Boyalife
    • 7.6.1 Boyalife Profile
    • 7.6.2 Boyalife Main Business
    • 7.6.3 Boyalife Cord Blood Storage Products, Services and Solutions
    • 7.6.4 Boyalife Cord Blood Storage Revenue (US$ Million) & (2020-2025)
    • 7.6.5 Boyalife Recent Developments
  • 7.7 LifeCell
    • 7.7.1 LifeCell Profile
    • 7.7.2 LifeCell Main Business
    • 7.7.3 LifeCell Cord Blood Storage Products, Services and Solutions
    • 7.7.4 LifeCell Cord Blood Storage Revenue (US$ Million) & (2020-2025)
    • 7.7.5 LifeCell Recent Developments
  • 7.8 Crioestaminal
    • 7.8.1 Crioestaminal Profile
    • 7.8.2 Crioestaminal Main Business
    • 7.8.3 Crioestaminal Cord Blood Storage Products, Services and Solutions
    • 7.8.4 Crioestaminal Cord Blood Storage Revenue (US$ Million) & (2020-2025)
    • 7.8.5 Crioestaminal Recent Developments
  • 7.9 Cryocord
    • 7.9.1 Cryocord Profile
    • 7.9.2 Cryocord Main Business
    • 7.9.3 Cryocord Cord Blood Storage Products, Services and Solutions
    • 7.9.4 Cryocord Cord Blood Storage Revenue (US$ Million) & (2020-2025)
    • 7.9.5 Cryocord Recent Developments
  • 7.10 Cryo-cell
    • 7.10.1 Cryo-cell Profile
    • 7.10.2 Cryo-cell Main Business
    • 7.10.3 Cryo-cell Cord Blood Storage Products, Services and Solutions
    • 7.10.4 Cryo-cell Cord Blood Storage Revenue (US$ Million) & (2020-2025)
    • 7.10.5 Cryo-cell Recent Developments
  • 7.11 Cordlife Group
    • 7.11.1 Cordlife Group Profile
    • 7.11.2 Cordlife Group Main Business
    • 7.11.3 Cordlife Group Cord Blood Storage Products, Services and Solutions
    • 7.11.4 Cordlife Group Cord Blood Storage Revenue (US$ Million) & (2020-2025)
    • 7.11.5 Cordlife Group Recent Developments
  • 7.12 PBKM FamiCord
    • 7.12.1 PBKM FamiCord Profile
    • 7.12.2 PBKM FamiCord Main Business
    • 7.12.3 PBKM FamiCord Cord Blood Storage Products, Services and Solutions
    • 7.12.4 PBKM FamiCord Cord Blood Storage Revenue (US$ Million) & (2020-2025)
    • 7.12.5 PBKM FamiCord Recent Developments
  • 7.13 cells4life
    • 7.13.1 cells4life Profile
    • 7.13.2 cells4life Main Business
    • 7.13.3 cells4life Cord Blood Storage Products, Services and Solutions
    • 7.13.4 cells4life Cord Blood Storage Revenue (US$ Million) & (2020-2025)
    • 7.13.5 cells4life Recent Developments
  • 7.14 Beikebiotech
    • 7.14.1 Beikebiotech Profile
    • 7.14.2 Beikebiotech Main Business
    • 7.14.3 Beikebiotech Cord Blood Storage Products, Services and Solutions
    • 7.14.4 Beikebiotech Cord Blood Storage Revenue (US$ Million) & (2020-2025)
    • 7.14.5 Beikebiotech Recent Developments
  • 7.15 StemCyte
    • 7.15.1 StemCyte Profile
    • 7.15.2 StemCyte Main Business
    • 7.15.3 StemCyte Cord Blood Storage Products, Services and Solutions
    • 7.15.4 StemCyte Cord Blood Storage Revenue (US$ Million) & (2020-2025)
    • 7.15.5 StemCyte Recent Developments
  • 7.16 Cellsafe Biotech Group
    • 7.16.1 Cellsafe Biotech Group Profile
    • 7.16.2 Cellsafe Biotech Group Main Business
    • 7.16.3 Cellsafe Biotech Group Cord Blood Storage Products, Services and Solutions
    • 7.16.4 Cellsafe Biotech Group Cord Blood Storage Revenue (US$ Million) & (2020-2025)
    • 7.16.5 Cellsafe Biotech Group Recent Developments
  • 7.17 PacifiCord
    • 7.17.1 PacifiCord Profile
    • 7.17.2 PacifiCord Main Business
    • 7.17.3 PacifiCord Cord Blood Storage Products, Services and Solutions
    • 7.17.4 PacifiCord Cord Blood Storage Revenue (US$ Million) & (2020-2025)
    • 7.17.5 PacifiCord Recent Developments
  • 7.18 Americord
    • 7.18.1 Americord Profile
    • 7.18.2 Americord Main Business
    • 7.18.3 Americord Cord Blood Storage Products, Services and Solutions
    • 7.18.4 Americord Cord Blood Storage Revenue (US$ Million) & (2020-2025)
    • 7.18.5 Americord Recent Developments
  • 7.19 Krio
    • 7.19.1 Krio Profile
    • 7.19.2 Krio Main Business
    • 7.19.3 Krio Cord Blood Storage Products, Services and Solutions
    • 7.19.4 Krio Cord Blood Storage Revenue (US$ Million) & (2020-2025)
    • 7.19.5 Krio Recent Developments
  • 7.20 Familycord
    • 7.20.1 Familycord Profile
    • 7.20.2 Familycord Main Business
    • 7.20.3 Familycord Cord Blood Storage Products, Services and Solutions
    • 7.20.4 Familycord Cord Blood Storage Revenue (US$ Million) & (2020-2025)
    • 7.20.5 Familycord Recent Developments
  • 7.21 Cryo Stemcell
    • 7.21.1 Cryo Stemcell Profile
    • 7.21.2 Cryo Stemcell Main Business
    • 7.21.3 Cryo Stemcell Cord Blood Storage Products, Services and Solutions
    • 7.21.4 Cryo Stemcell Cord Blood Storage Revenue (US$ Million) & (2020-2025)
    • 7.21.5 Cryo Stemcell Recent Developments
  • 7.22 Vinmec Tissue Bank
    • 7.22.1 Vinmec Tissue Bank Profile
    • 7.22.2 Vinmec Tissue Bank Main Business
    • 7.22.3 Vinmec Tissue Bank Cord Blood Storage Products, Services and Solutions
    • 7.22.4 Vinmec Tissue Bank Cord Blood Storage Revenue (US$ Million) & (2020-2025)
    • 7.22.5 Vinmec Tissue Bank Recent Developments
  • 7.23 StemCord
    • 7.23.1 StemCord Profile
    • 7.23.2 StemCord Main Business
    • 7.23.3 StemCord Cord Blood Storage Products, Services and Solutions
    • 7.23.4 StemCord Cord Blood Storage Revenue (US$ Million) & (2020-2025)
    • 7.23.5 StemCord Recent Developments
  • 7.24 IPSC Depository
    • 7.24.1 IPSC Depository Profile
    • 7.24.2 IPSC Depository Main Business
    • 7.24.3 IPSC Depository Cord Blood Storage Products, Services and Solutions
    • 7.24.4 IPSC Depository Cord Blood Storage Revenue (US$ Million) & (2020-2025)
    • 7.24.5 IPSC Depository Recent Developments
  • 7.25 Thai StemLife
    • 7.25.1 Thai StemLife Profile
    • 7.25.2 Thai StemLife Main Business
    • 7.25.3 Thai StemLife Cord Blood Storage Products, Services and Solutions
    • 7.25.4 Thai StemLife Cord Blood Storage Revenue (US$ Million) & (2020-2025)
    • 7.25.5 Thai StemLife Recent Developments
  • 7.26 Cryoviva
    • 7.26.1 Cryoviva Profile
    • 7.26.2 Cryoviva Main Business
    • 7.26.3 Cryoviva Cord Blood Storage Products, Services and Solutions
    • 7.26.4 Cryoviva Cord Blood Storage Revenue (US$ Million) & (2020-2025)
    • 7.26.5 Cryoviva Recent Developments

8 Industry Chain Analysis

  • 8.1 Cord Blood Storage Industrial Chain
  • 8.2 Cord Blood Storage Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Cord Blood Storage Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Cord Blood Storage Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제